Emblem Pharmaceuticals Private Limited
About Emblem Pharmaceuticals Private Limited
Data last updated:
Emblem Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 31 October 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC307716. Its GSTIN is 09AAECE4356N1Z6 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vishal Tyagi and Prashant Tyagi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No – 631 Ff Kh No – 226 Gali No – 14 Mandooli Near Shiv Mandir, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.41 Lakh, a decline of 58% compared to the previous year. For the same year it recorded a net loss of ₹97,485 (net margin -40.4%) and EBITDA of -₹97,485 (EBITDA margin -40.4%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 13% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Emblem Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No – 631 Ff Kh No – 226 Gali No – 14 Mandooli Near Shiv Mandir, Delhi, India – 110094
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Emblem Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Emblem Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Emblem Pharmaceuticals Private Limited, buy the company report.
Financials of Emblem Pharmaceuticals Private Limited
FY 2025 filings availableEmblem Pharmaceuticals Private Limited reported revenue of ₹2.41 Lakh (down 58% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 58% fall in the latest year. EBITDA fell 463% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹97,485 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹97,485 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -40.4% | ||||
| Net Profit Margin | -40.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Emblem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Emblem Pharmaceuticals Private Limited
Emblem Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vishal Tyagi | Director | 31 Oct 2016 | 9 Years 11 Months | Current |
| Prashant Tyagi | Director | 31 Oct 2016 | 9 Years 11 Months | Current |
Peer comparison
Emblem Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Albert Pharmaceuticals Private Limited | ₹2.43 Lakh (FY 2021) | -49.0% | Gopalganj, Bihar, India | |||
| Emblem Pharmaceuticals Private Limitedthis company | ₹2.41 Lakh (FY 2025) | -₹97,485 | -40.4% | -58.0% | Delhi, India | |
| Evoluent Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2021) | -55.0% | Palace Guttahalli, Karnataka, India | |||
| Omish Pharmaceuticals Private Limited | ₹2.41 Lakh (FY 2023) | -93.0% | Delhi, India |
To see the full peer comparison of Emblem Pharmaceuticals Private Limited, buy the company report.
Auditor
Emblem Pharmaceuticals Private Limited is audited by Ujjwal Singhal for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ujjwal Singhal | FY 2017 | UJJWAL SINGHAL & CO. |
Shareholding
The shareholding of Emblem Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Emblem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Emblem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Emblem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Emblem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECE4356N1Z6 | Uttar Pradesh | Active | 07 Mar 2018 |
To see the full GST registrations and return filing status of Emblem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Emblem Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Prashant Tyagi was appointed as Director on 31 Oct 2016.
Frequently asked questions
Emblem Pharmaceuticals is an active private limited company based in Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 31 October 2016 (10+ years old) and is registered under CIN U74999DL2016PTC307716.
Emblem Pharmaceuticals has 2 current directors:
- Vishal Tyagi - Director
- Prashant Tyagi - Director
The latest financial statements of Emblem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Emblem Pharmaceuticals is 09AAECE4356N1Z6, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Emblem Pharmaceuticals is U74999DL2016PTC307716. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Emblem Pharmaceuticals was incorporated on 31 October 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Emblem Pharmaceuticals by revenue are Albert Pharmaceuticals Private Limited, Evoluent Pharmaceuticals Private Limited, Omish Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Prashant Tyagi was appointed as Director on 31 Oct 2016. Vishal Tyagi was appointed as Director on 31 Oct 2016.
The registered office of Emblem Pharmaceuticals is at House No – 631 Ff Kh No – 226 Gali No – 14 Mandooli Near Shiv Mandir, Delhi, India – 110094.
Emblem Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Emblem Pharmaceuticals is compliant as of 08 August 2026. The company is actively filing with the Registrar of Companies.